Fundraising FoxR3 Vascular
Mountain View, US · Founded 2019 · Delaware corporation · 1 known investors
Find your way into R3 Vascular
Sign up to see every warm intro you have to R3 Vascular
- Paths you didn't know you had: your email and LinkedIn already hold routes to the R3 Vascular team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
R3 Vascular develops bioresorbable vascular scaffolds made from a proprietary polymer using a proprietary manufacturing process. It operates in the medical device field for vascular treatment.
Founders & leadership
R3 Vascular was founded in 2019 by Kamal Ramzipoor.
CM
Christopher M. OwensPresident and Chief Executive Officer
MR
Mahmood RazaviNamed on SEC filing
JM
JeanMarie MarkhamNamed on SEC filing
Board
FG
JS
John SpringerBoard director
MH
Michael HurleyBoard director
DN
David NeustaedterBoard director
NH
Nathan HarringtonBoard director
AA
Amir AbolfathiBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$75.2M disclosed across 2 rounds · 2019–2024
▶$72.5MraisedSep 2024 · 34 investors · Other Health CareRule 506(b)
▶$72.5MraisedSep 2024 · 34 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kamal RamzipoorExecutive Officer
- Frederik GroenewegenDirector
- John SpringerDirector
- Michael HurleyDirector
- David NeustaedterDirector
- Christopher M. OwensExecutive Officer, Director
- Amir AbolfathiDirector
- Nathan HarringtonDirector
- Amount sold
- $72.5M
- Minimum investment
- $331
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.7MraisedMay 2020 · 23 investors · Other Health CareRule 506(c)
▶$2.7MraisedMay 2020 · 23 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Kamal RamzipoorDirector
- Mahmood RazaviDirector
- JeanMarie MarkhamDirector
- John SpringerExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $2.7M
- Minimum investment
- $25K
- Sales commissions
- $15K
- Proceeds to insiders
- $450K
- Placement agents
- Beech Hill Securities, Inc
- First sale
- Aug 2019
- Incorporated
- Corporation, California, 2019
- Federal exemptions
- 04, 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as R3 Vascular.
In the news
Frequently asked questions
- What does R3 Vascular do?
- R3 Vascular develops bioresorbable vascular scaffolds made from a proprietary polymer using a proprietary manufacturing process. It operates in the medical device field for vascular treatment.
- Who founded R3 Vascular?
- R3 Vascular was founded by Kamal Ramzipoor in 2019.
- Who are R3 Vascular's investors?
- R3 Vascular's investors include 415 Capital.
- How much funding has R3 Vascular raised?
- R3 Vascular has disclosed $75.2M raised across 2 rounds.
- Where is R3 Vascular headquartered?
- R3 Vascular is headquartered in Mountain View, US.